← Back to Search

Tobacco Cessation Treatment for Peripheral Arterial Disease (PAD Trial)

N/A
Waitlist Available
Led By Darla E Kendzor, PhD
Research Sponsored by University of Oklahoma
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
18 years of age or older
Diagnosed with peripheral artery disease
Timeline
Screening 3 weeks
Treatment Varies
Follow Up duration of the study (approximately 6 months)
Awards & highlights

PAD Trial Summary

This trial is testing whether integrating tobacco cessation services into a dedicated peripheral artery disease clinic can improve quitting rates and health outcomes in PAD patients.

Who is the study for?
This trial is for adults over 18 who have been diagnosed with peripheral artery disease (PAD) and currently use tobacco. Participants must be able to attend all study visits and understand English. Those without PAD or unable to meet these requirements cannot join.Check my eligibility
What is being tested?
The trial tests a Tobacco Treatment Research Program that includes nicotine replacement therapy, counseling, and questionnaires designed to help patients quit smoking, aiming to improve health outcomes for those with PAD.See study design
What are the potential side effects?
Potential side effects may include typical reactions to nicotine replacement like headaches, nausea, dizziness, insomnia, skin irritation from patches or gum-related issues such as jaw discomfort.

PAD Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
I have been diagnosed with peripheral artery disease.

PAD Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~duration of the study (approximately 6 months)
This trial's timeline: 3 weeks for screening, Varies for treatment, and duration of the study (approximately 6 months) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Biochemically confirmed abstinence
Secondary outcome measures
Rate of enrollment
Other outcome measures
Improvements in PAD

PAD Trial Design

1Treatment groups
Experimental Treatment
Group I: Standard CareExperimental Treatment1 Intervention
All participants will receive standard care by the Tobacco Treatment Research Program. This includes nicotine replacement therapy such as patches, gum, or lozenges, counseling by a Tobacco Treatment Specialist, and complete questionnaires.

Find a Location

Who is running the clinical trial?

University of OklahomaLead Sponsor
455 Previous Clinical Trials
98,167 Total Patients Enrolled
7 Trials studying Peripheral Arterial Disease
1,365 Patients Enrolled for Peripheral Arterial Disease
Darla E Kendzor, PhDPrincipal InvestigatorUniversity of Oklahoma

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Am I eligible to partake in this experiment?

"With peripheral arterial disease, 40 individuals aged 18 to 100 are being enrolled in this trial. To qualify for participation certain factors must be met: a medical diagnosis of PAD, the ability to understand English and commit to all scheduled appointments, as well as being an active tobacco user."

Answered by AI

Does the current study require more participants?

"As per the clinicaltrials.gov website, this experiment is currently not taking in participants. This research project was initially posted on August 16th 2022 and recently updated October 3rd of that same year. Despite being inactive for recruitment at present, there are 226 other trials actively seeking volunteers now."

Answered by AI

Is this specific research open to participants aged 65 and up?

"The lower age limit for inclusion in this medical trial is 18, while the upper threshold to be eligible stands at 100 years old."

Answered by AI
~6 spots leftby Mar 2025